Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter

Y. Takamatsu, Y. Hagino, A. Sato, T. Takahashi, S. Y. Nagasawa, Y. Kubo, M. Mizuguchi, G. R. Uhl, I. Sora, K. Ikeda

Research output: Contribution to journalArticle

Abstract

The symptoms of attention-deficit/hyperactivity disorder (ADHD) are characterized by inattention and hyperactivity-impulsivity. It is a common childhood neurodevelopmental disorder that often persists into adulthood. Improvements in ADHD symptoms using psychostimulants have been recognized as a paradoxical calming effect. The psychostimulant methylphenidate (MPH) is currently used as the first-line medication for the management of ADHD. Recent studies have drawn attention to altered dopamine-mediated neurotransmission in ADHD, particularly reuptake by the dopamine transporter (DAT). This hypothesis is supported by the observation that DAT knockout mice exhibit marked hyperactivity that is responsive to acute MPH treatment. However, other behaviors relevant to ADHD have not been fully clarified. In the present study, we observed learning impairment in shuttle-box avoidance behavior together with hyperactivity in a novel environment in DAT knockout mice. Methylphenidate normalized these behaviors and enhanced escape activity in the tail suspension test. Interestingly, the effective dose of MPH increased extracellular dopamine in the prefrontal cortex but not striatum, suggesting an important role for changes in prefrontal dopamine in ADHD. Research that uses rodent models such as DAT knockout mice may be useful for elucidating the pathophysiology of ADHD.

Original languageEnglish (US)
Pages (from-to)245-252
Number of pages8
JournalCurrent Molecular Medicine
Volume15
Issue number3
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Dopamine Plasma Membrane Transport Proteins
Methylphenidate
Frontal Lobe
Attention Deficit Disorder with Hyperactivity
Dopamine
Learning
Knockout Mice
Suspensions
Avoidance Learning
Hindlimb Suspension
Impulsive Behavior
Prefrontal Cortex
Synaptic Transmission
Rodentia
Research

Keywords

  • ADHD
  • Dopamine transporter
  • Frontal cortex
  • Knockout
  • Learning
  • Methylphenidate
  • Norepinephrine transporter

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Medicine(all)

Cite this

Takamatsu, Y., Hagino, Y., Sato, A., Takahashi, T., Nagasawa, S. Y., Kubo, Y., ... Ikeda, K. (2015). Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter. Current Molecular Medicine, 15(3), 245-252.

Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter. / Takamatsu, Y.; Hagino, Y.; Sato, A.; Takahashi, T.; Nagasawa, S. Y.; Kubo, Y.; Mizuguchi, M.; Uhl, G. R.; Sora, I.; Ikeda, K.

In: Current Molecular Medicine, Vol. 15, No. 3, 01.05.2015, p. 245-252.

Research output: Contribution to journalArticle

Takamatsu, Y, Hagino, Y, Sato, A, Takahashi, T, Nagasawa, SY, Kubo, Y, Mizuguchi, M, Uhl, GR, Sora, I & Ikeda, K 2015, 'Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter', Current Molecular Medicine, vol. 15, no. 3, pp. 245-252.
Takamatsu, Y. ; Hagino, Y. ; Sato, A. ; Takahashi, T. ; Nagasawa, S. Y. ; Kubo, Y. ; Mizuguchi, M. ; Uhl, G. R. ; Sora, I. ; Ikeda, K. / Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter. In: Current Molecular Medicine. 2015 ; Vol. 15, No. 3. pp. 245-252.
@article{98e190bc1ddb435897f44d46d4cb6c2b,
title = "Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter",
abstract = "The symptoms of attention-deficit/hyperactivity disorder (ADHD) are characterized by inattention and hyperactivity-impulsivity. It is a common childhood neurodevelopmental disorder that often persists into adulthood. Improvements in ADHD symptoms using psychostimulants have been recognized as a paradoxical calming effect. The psychostimulant methylphenidate (MPH) is currently used as the first-line medication for the management of ADHD. Recent studies have drawn attention to altered dopamine-mediated neurotransmission in ADHD, particularly reuptake by the dopamine transporter (DAT). This hypothesis is supported by the observation that DAT knockout mice exhibit marked hyperactivity that is responsive to acute MPH treatment. However, other behaviors relevant to ADHD have not been fully clarified. In the present study, we observed learning impairment in shuttle-box avoidance behavior together with hyperactivity in a novel environment in DAT knockout mice. Methylphenidate normalized these behaviors and enhanced escape activity in the tail suspension test. Interestingly, the effective dose of MPH increased extracellular dopamine in the prefrontal cortex but not striatum, suggesting an important role for changes in prefrontal dopamine in ADHD. Research that uses rodent models such as DAT knockout mice may be useful for elucidating the pathophysiology of ADHD.",
keywords = "ADHD, Dopamine transporter, Frontal cortex, Knockout, Learning, Methylphenidate, Norepinephrine transporter",
author = "Y. Takamatsu and Y. Hagino and A. Sato and T. Takahashi and Nagasawa, {S. Y.} and Y. Kubo and M. Mizuguchi and Uhl, {G. R.} and I. Sora and K. Ikeda",
year = "2015",
month = "5",
day = "1",
language = "English (US)",
volume = "15",
pages = "245--252",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter

AU - Takamatsu, Y.

AU - Hagino, Y.

AU - Sato, A.

AU - Takahashi, T.

AU - Nagasawa, S. Y.

AU - Kubo, Y.

AU - Mizuguchi, M.

AU - Uhl, G. R.

AU - Sora, I.

AU - Ikeda, K.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The symptoms of attention-deficit/hyperactivity disorder (ADHD) are characterized by inattention and hyperactivity-impulsivity. It is a common childhood neurodevelopmental disorder that often persists into adulthood. Improvements in ADHD symptoms using psychostimulants have been recognized as a paradoxical calming effect. The psychostimulant methylphenidate (MPH) is currently used as the first-line medication for the management of ADHD. Recent studies have drawn attention to altered dopamine-mediated neurotransmission in ADHD, particularly reuptake by the dopamine transporter (DAT). This hypothesis is supported by the observation that DAT knockout mice exhibit marked hyperactivity that is responsive to acute MPH treatment. However, other behaviors relevant to ADHD have not been fully clarified. In the present study, we observed learning impairment in shuttle-box avoidance behavior together with hyperactivity in a novel environment in DAT knockout mice. Methylphenidate normalized these behaviors and enhanced escape activity in the tail suspension test. Interestingly, the effective dose of MPH increased extracellular dopamine in the prefrontal cortex but not striatum, suggesting an important role for changes in prefrontal dopamine in ADHD. Research that uses rodent models such as DAT knockout mice may be useful for elucidating the pathophysiology of ADHD.

AB - The symptoms of attention-deficit/hyperactivity disorder (ADHD) are characterized by inattention and hyperactivity-impulsivity. It is a common childhood neurodevelopmental disorder that often persists into adulthood. Improvements in ADHD symptoms using psychostimulants have been recognized as a paradoxical calming effect. The psychostimulant methylphenidate (MPH) is currently used as the first-line medication for the management of ADHD. Recent studies have drawn attention to altered dopamine-mediated neurotransmission in ADHD, particularly reuptake by the dopamine transporter (DAT). This hypothesis is supported by the observation that DAT knockout mice exhibit marked hyperactivity that is responsive to acute MPH treatment. However, other behaviors relevant to ADHD have not been fully clarified. In the present study, we observed learning impairment in shuttle-box avoidance behavior together with hyperactivity in a novel environment in DAT knockout mice. Methylphenidate normalized these behaviors and enhanced escape activity in the tail suspension test. Interestingly, the effective dose of MPH increased extracellular dopamine in the prefrontal cortex but not striatum, suggesting an important role for changes in prefrontal dopamine in ADHD. Research that uses rodent models such as DAT knockout mice may be useful for elucidating the pathophysiology of ADHD.

KW - ADHD

KW - Dopamine transporter

KW - Frontal cortex

KW - Knockout

KW - Learning

KW - Methylphenidate

KW - Norepinephrine transporter

UR - http://www.scopus.com/inward/record.url?scp=84929614305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929614305&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 245

EP - 252

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 3

ER -